COMPOSITION
Each envelope contains:
Glucosamine ………………. ………. …. …… 1500 mg
Chondroitin ………………. ………. …… .. …… 1200 mg
Excipients ………. ……………. ……………… c.s.p.
PHARMACEUTICAL FORM
Powder for oral suspension
CLINICAL DATA
Therapeutic indications
It is indicated in degenerative osteo-articular disease, primary and secondary osteoarthritis: Cervical arthrosis, coxofemoral, artosis of the knee, lumbar, dorsal and sacral, scapulohumeral, osteoarticular dystrophies.
Administration
Orally
Contraindications
Hypersensitivity to any of the components of the formula.
Presentation
Box containing 30 envelopes
Available in:
Manufacturer:
Go to Website